{"database": "lobbying", "table": "lobbying_activities", "rows": [[2513668, "fa094052-2b40-415d-8663-98c03a718cb0", "Q3", "FORBES-TATE", 400976792, "NOVARTIS, INC.", 2020, "third_quarter", "CPT", "Issues related to prescription drug pricing, the United States-Mexico-Canada Agreement (USMCA), and Intellectual Property (IP); Issues related to H.R. 748 - the CARES Act (Pub.L. 116-136).", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2020-10-18T15:35:38.930000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2513668"], "units": {}, "query_ms": 32.026113010942936, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}